Bausch Health Companies Inc. (BHC) trades at a trailing P/E of 12.5, forward P/E of 1.3. Trailing earnings yield is 7.97%, forward earnings yield 76.34%. Graham Number is $3.09.
Criteria proven by this page:
Overall SharesGrow Score: 55/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -2.1 | 0.00 | 1.60 | 0.52 | - |
| 2017 | 3.0 | -0.01 | 1.24 | 0.83 | - |
| 2018 | -1.6 | 0.01 | 2.36 | 0.77 | - |
| 2019 | -5.9 | 0.10 | 9.91 | 1.22 | - |
| 2020 | -13.2 | 0.19 | 13.80 | 0.92 | - |
| 2021 | -10.5 | -0.16 | -93.48 | 1.17 | - |
| 2022 | -10.1 | 0.13 | -3.29 | 0.28 | - |
| 2023 | -5.0 | -0.03 | -2.87 | 0.33 | - |
| 2024 | -64.5 | 0.70 | -2.32 | 0.31 | - |
| 2025 | 16.6 | -0.04 | -4.66 | 0.25 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-6.94 | $9.67B | $-2.41B | -24.9% |
| 2017 | $8.59 | $8.72B | $2.4B | 27.6% |
| 2018 | $-11.86 | $8.38B | $-4.15B | -49.5% |
| 2019 | $-5.06 | $8.6B | $-1.78B | -20.7% |
| 2020 | $-1.57 | $8.03B | $-559M | -7% |
| 2021 | $-2.61 | $8.43B | $-937M | -11.1% |
| 2022 | $-0.59 | $8.12B | $-212M | -2.6% |
| 2023 | $-1.62 | $8.76B | $-592M | -6.8% |
| 2024 | $-0.13 | $9.52B | $-43.79M | -0.5% |
| 2025 | $0.41 | $10.31B | $155.28M | 1.5% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $4.30 | $4.04 – $4.92 | $10.51B | $10.52B – $10.56B | 4 |
| 2027 | $4.05 | $3.64 – $4.32 | $10.53B | $10.54B – $10.58B | 5 |
| 2028 | $3.04 | $3.03 – $3.06 | $9.68B | $9.63B – $9.79B | 2 |
| 2029 | $3.29 | $3.27 – $3.31 | $9.59B | $9.57B – $9.66B | 1 |
| 2030 | $3.55 | $3.53 – $3.57 | $9.61B | $9.6B – $9.68B | 1 |
